Stocks in Play

HLS Therapeutics Inc.

10:50 AM EST - HLS Therapeutics Inc. : Announces that it has entered into an agreement with Bayer Inc. to commercialize VERQUVO® (vericiguat) in Canada. HLS Therapeutics Inc. shares T.HLS are trading up $0.03 at $4.50.